ANGPT1 and ischemic stroke: Moreover, the administration of a synthetic liver X receptor agonist (GW3965) has been reported to increase Ang1/Tie2 signaling pathway activity in the ischemic brain, thus enhancing NVU function and consequently attenuating ischemic stroke damage [93].